Diisopropylcarbodiimide → HCID 59286587, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][C:11]=1[O:12][CH3:13])[CH:8]=[N:7][C:6]([NH:14][C:15]([NH:17][CH2:18][C@@:19]1([OH:27])[CH:24]3[CH2:25][CH2:26][N:21]([CH2:22][CH2:23]3)[CH2:20]1)=S)=[CH:5]2.C(=NC(C)C)=NC(C)C>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][C:11]=1[O:12][CH3:13])[CH:8]=[N:7][C:6]([NH:14][C:15]1[O:27][C@:19]3([CH2:18][N:17]=1)[CH:24]1[CH2:25][CH2:26][N:21]([CH2:22][CH2:23]1)[CH2:20]3)=[CH:5]2Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (S)-1-(6-chloro-7-methoxyisoquinolin-3-yl)-3-((3-hydroxyquinuclidin-3-yl)methyl)thiourea (140 mg, 0.344 mmol) in DMF (2.5 mL) was added a solution of N,N′-methanediylidenedipropan-2-amine (101 mg, 0.800 mmol) in DMF (0.5 mL) and the resulting mixture was allowed to stand at room temperature for 10 days. The solvent was then evaporated in vacuo. The residue was dissolved in ˜5 mL MeOH (some white solid was filtered off, 09) and subjected to preparative HPLC purification followed by silica gel chromatography in 1% NH4OH/9% MeOH/90% CHCl3 to give 31 mg (24%) (R)—N-(6-chloro-7-methoxyisoquinolin-3-yl)-4H-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octan]-2-amine LCMS RT 1.04 min, MH+=373.2, 375.2 1H NMR (500 MHz, MeOD) δ ppm 8.78-8.89 (1H, m), 7.90-8.01 (1H, m), 7.14-7.23 (1H, m), 4.01 (3H, s), 3.95-3.99 (1H, m), 3.62-3.71 (1H, m), 3.19-3.25 (1H, m), 3.06-3.13 (1H, m), 2.90-3.00 (2H, m), 2.76-2.89 (2H, m), 2.10-2.21 (2H, m), 1.69-1.83 (2H, m), 1.56-1.68 (1H, m).
Workup
- customThe solvent was then evaporated in vacuo
- dissolutionThe residue was dissolved in ˜5 mL MeOH (some white solid
- filtrationwas filtered off
- custom09) and subjected to preparative HPLC purification
Sources & evidence
- ORD record
- ord-39f3254a0bcf4e45b75bd8890265f162
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08309577B2
Reaction notes
Loading…